Group One Trading
OTLK icon

Group One Trading’s Outlook Therapeutics OTLK Stock Holding History

Group One Trading’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.9K Buy
15,000
+10,500
+233% +$6.51K ﹤0.01% 5898
2026
Q1 		$926 Sell
4,500
-72,100
-94% -$31.2K ﹤0.01% 7223
2025
Q4 		$121K Buy
76,600
+71,100
+1,293% +$114K ﹤0.01% 4837
2025
Q3 		$5.83K Sell
5,500
-3,500
-39% -$6.05K ﹤0.01% 7465
2025
Q2 		$14.4K Hold
9,000
– – ﹤0.01% 6485
2025
Q1 		$11K Buy
+9,000
New +$15.8K ﹤0.01% 6197
2024
Q4 		– Sell
-400
Closed -$2.14K – 7777
2024
Q3 		$2.14K Buy
+400
New +$2.93K ﹤0.01% 6127

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM

Group One Trading's OTLK Position: Q2 2026 in Review

Group One Trading increased its Outlook Therapeutics (OTLK) stake by 117% in Q2 2026, buying an estimated $82.3K and bringing the position to 246,428 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #3723.

Group One Trading first reported a position in OTLK in Q1 2025 and has held it in 6 quarters since. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Group One Trading held 246,428 shares of Outlook Therapeutics worth $392K as of Q2 2026.
  • Group One Trading bought 132,727 Outlook Therapeutics shares in Q2 2026, an estimated $82.3K.
  • Outlook Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3723 holding.
  • Group One Trading first reported a position in Outlook Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.